Bernadette Hugon, Fabrice Anizon, Christian Bailly, Roy M Golsteyn, Alain Pierré, Stéphane Léonce, John Hickman, Bruno Pfeiffer, Michelle Prudhomme
Index: Bioorg. Med. Chem. 15(17) , 5965-80, (2007)
Full Text: HTML
The synthesis of new isogranulatimide analogues, their inhibitory activities toward the Checkpoint 1 kinase (Chk1), and their in vitro cytotoxicities toward four tumor cell lines (one murine L1210 leukemia, and three human cell lines: DU145 prostate carcinoma, A549 non-small cell lung carcinoma, and HT29 colon carcinoma) are described. The affinity for DNA of some representative compounds and their ability to induce DNA cleavage mediated by topoisomerase I have been examined. In some of the newly synthesized compounds, the imidazole heterocycle of isogranulatimide is replaced by a pyrrole and/or the indole unit is replaced by a 7-azaindole. Compounds in which a sugar part is attached to the 7-azaindole moiety have also been prepared. Some of the newly synthesized compounds are more potent Chk1 inhibitors than granulatimide. The selectivity of two potent Chk1 inhibitors 24 and 26 has been evaluated using various kinases. The strongest inhibitory properties are found toward Chk1.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Rebeccamycin
CAS:93908-02-2 |
C27H21Cl2N3O7 |
Structure and mechanism of the rebeccamycin sugar 4'-O-methy...
2008-08-15 [J. Biol. Chem. 283(33) , 22628-36, (2008)] |
Natural product diversification using a non-natural cofactor...
2006-03-08 [J. Am. Chem. Soc. 128(9) , 2760-1, (2006)] |
Engineering biosynthetic pathways to generate antitumor indo...
2006-07-01 [J. Ind. Microbiol. Biotechnol. 33(7) , 560-8, (2006)] |
Flavin redox chemistry precedes substrate chlorination durin...
2006-06-27 [Biochemistry 45(25) , 7904-12, (2006)] |
Rebeccamycin derivatives as dual DNA-damaging agents and pot...
2008-12-01 [Mol. Pharmacol. 74(6) , 1620-9, (2008)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved